+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cholinergic Involvement in Neurodegenerative Diseases. Handbook of Clinical Neurology Volume 211

  • Book

  • June 2025
  • Elsevier Science and Technology
  • ID: 6035840

Cholinergic Involvement in Neurodegenerative Diseases, Volume 211 reviews cholinergic function in the brain as it relates to Neurodegenerative disorders. Coverage includes Alzheimer’s, dementia, Down Syndrome, Parkinson’s, Huntington’s, ALS, and more. In addition, the anatomy of the cholinergic system is described as well as the distribution and function of receptors.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. The history of the CNS cholinergic transmission
2. Organization of the basal forebrain cholinergic system in the human brain
3. The cholinergic synapses
4. Nicotinic acetylcholine receptors in the brain
5. Cognition and modulation of the cholinergic system
6. The involvement of the cholinergic system in Alzheimer disease
7. Structural changes to the basal forebrain cholinergic system in the continuum of the Alzheimer’s pathology
8. The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathology
9. NGF based cholinergic therapies in Alzheimer disease
10. Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission
11. Cholinergic therapy in Alzheimer’s disease
12. CNS muscarinic receptors agonists in Alzheimer’s disease treatment
13. The Cholinergic system in down syndrome
14. The Cholinergic system in Parkinson disease
15. The Cholinergic system in dementia with Lewy bodies
16. Epilogue. Standing on the shoulders of giants-Charting the future of cholinergic research

Authors

A. Claudio Cuello Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada. A. Claudio Cuello works in the Department of Pharmacology and Therapeutics at McGill University in Montreal, Quebec, Canada.